Reflections on treatment of IBD in children and adolescents

Geneviève Veereman; Bruno Hauser; Elisabeth De Greef; Thierry Devreker; Koen Huysentruyt; Roel Lemmens; Yvan Vandenplas

doi:10.1080/08923973.2018.1474922

Reflections on treatment of IBD in children and adolescents

Geneviève Veereman, Bruno Hauser, Elisabeth De Greef, Thierry Devreker, Koen Huysentruyt, Roel Lemmens, Yvan Vandenplas

Onderzoeksoutput: Article › peer review

Samenvatting

Major pharmaceutical advancements in the field of inflammatory bowel diseases benefit to children and adolescents affected with this progressive chronic condition. Scientific organisations such as ESPGHAN and ECCO actively publish guidelines related to the many aspects of care from these patients. Clinical studies and long-term prospective registries in the appropriate age groups are crucial to support an evidence based strategy.

Originele taal-2	English
Pagina's (van-tot)	461-464
Aantal pagina's	4
Tijdschrift	Immunopharmacology and Immunotoxicology
Volume	40
Nummer van het tijdschrift	6
Vroegere onlinedatum	24 jul 2018
DOI's	https://doi.org/10.1080/08923973.2018.1474922
Status	Published - 24 jul 2018

Toegang tot document

10.1080/08923973.2018.1474922

Andere bestanden en links

Link to publication in Scopus

Citeer dit

@article{65de80c53146474d8c65babd35a6a817,

title = "Reflections on treatment of IBD in children and adolescents",

abstract = "Major pharmaceutical advancements in the field of inflammatory bowel diseases benefit to children and adolescents affected with this progressive chronic condition. Scientific organisations such as ESPGHAN and ECCO actively publish guidelines related to the many aspects of care from these patients. Clinical studies and long-term prospective registries in the appropriate age groups are crucial to support an evidence based strategy.",

keywords = "Inflammatory bowel disease, children, clinical studies, pediatrics, treatment",

author = "Genevi{\`e}ve Veereman and Bruno Hauser and {De Greef}, Elisabeth and Thierry Devreker and Koen Huysentruyt and Roel Lemmens and Yvan Vandenplas",

year = "2018",

month = jul,

day = "24",

doi = "10.1080/08923973.2018.1474922",

language = "English",

volume = "40",

pages = "461--464",

journal = "Immunopharmacology and Immunotoxicology",

issn = "0892-3973",

publisher = "Taylor & Francis",

number = "6",

}

TY - JOUR

T1 - Reflections on treatment of IBD in children and adolescents

AU - Veereman, Geneviève

AU - Hauser, Bruno

AU - De Greef, Elisabeth

AU - Devreker, Thierry

AU - Huysentruyt, Koen

AU - Lemmens, Roel

AU - Vandenplas, Yvan

PY - 2018/7/24

Y1 - 2018/7/24

N2 - Major pharmaceutical advancements in the field of inflammatory bowel diseases benefit to children and adolescents affected with this progressive chronic condition. Scientific organisations such as ESPGHAN and ECCO actively publish guidelines related to the many aspects of care from these patients. Clinical studies and long-term prospective registries in the appropriate age groups are crucial to support an evidence based strategy.

AB - Major pharmaceutical advancements in the field of inflammatory bowel diseases benefit to children and adolescents affected with this progressive chronic condition. Scientific organisations such as ESPGHAN and ECCO actively publish guidelines related to the many aspects of care from these patients. Clinical studies and long-term prospective registries in the appropriate age groups are crucial to support an evidence based strategy.

KW - Inflammatory bowel disease

KW - children

KW - clinical studies

KW - pediatrics

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85063091663&partnerID=8YFLogxK

U2 - 10.1080/08923973.2018.1474922

DO - 10.1080/08923973.2018.1474922

M3 - Article

C2 - 30040512

VL - 40

SP - 461

EP - 464

JO - Immunopharmacology and Immunotoxicology

JF - Immunopharmacology and Immunotoxicology

SN - 0892-3973

IS - 6

ER -

Reflections on treatment of IBD in children and adolescents

Samenvatting

Toegang tot document

Andere bestanden en links

Vingerafdruk

Citeer dit